A detailed history of California State Teachers Retirement System transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, California State Teachers Retirement System holds 134,270 shares of ABUS stock, worth $487,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134,270
Previous 10,107 1228.49%
Holding current value
$487,400
Previous $31,000 1564.52%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.12 - $4.56 $387,388 - $566,183
124,163 Added 1228.49%
134,270 $516,000
Q2 2024

Aug 14, 2024

SELL
$2.52 - $3.63 $6,627 - $9,546
-2,630 Reduced 20.65%
10,107 $31,000
Q1 2024

May 15, 2024

SELL
$2.26 - $2.92 $18,344 - $23,701
-8,117 Reduced 38.92%
12,737 $32,000
Q4 2023

Feb 13, 2024

SELL
$1.69 - $2.54 $11,301 - $16,984
-6,687 Reduced 24.28%
20,854 $52,000
Q3 2023

Nov 14, 2023

SELL
$1.9 - $2.27 $26,562 - $31,734
-13,980 Reduced 33.67%
27,541 $55,000
Q2 2023

Aug 21, 2023

SELL
$2.24 - $3.06 $1,610 - $2,200
-719 Reduced 1.7%
41,521 $95,000
Q1 2023

May 09, 2023

SELL
$2.23 - $3.1 $8,750 - $12,164
-3,924 Reduced 8.5%
42,240 $127,000
Q4 2022

Feb 14, 2023

BUY
$1.91 - $2.85 $6,757 - $10,083
3,538 Added 8.3%
46,164 $107,000
Q3 2022

Nov 18, 2022

SELL
$1.88 - $2.88 $6,681 - $10,235
-3,554 Reduced 7.7%
42,626 $81,000
Q2 2022

Aug 15, 2022

BUY
$1.98 - $3.17 $14,800 - $23,695
7,475 Added 19.31%
46,180 $125,000
Q1 2022

May 16, 2022

SELL
$2.42 - $3.98 $11,824 - $19,446
-4,886 Reduced 11.21%
38,705 $115,000
Q4 2021

Feb 15, 2022

BUY
$3.11 - $4.61 $4,441 - $6,583
1,428 Added 3.39%
43,591 $170,000
Q3 2021

Nov 15, 2021

SELL
$2.65 - $4.62 $174,714 - $304,596
-65,930 Reduced 60.99%
42,163 $181,000
Q2 2021

Aug 16, 2021

BUY
$2.5 - $3.51 $270,232 - $379,406
108,093 New
108,093 $328,000
Q2 2019

Aug 14, 2019

SELL
$1.46 - $4.44 $79,862 - $242,868
-54,700 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$3.41 - $4.57 $23,610 - $31,642
-6,924 Reduced 11.24%
54,700 $196,000
Q4 2018

Feb 13, 2019

BUY
$3.5 - $9.66 $25,305 - $69,841
7,230 Added 13.29%
61,624 $236,000
Q3 2018

Nov 14, 2018

BUY
$7.85 - $12.35 $2,802 - $4,408
357 Added 0.66%
54,394 $514,000
Q2 2018

Aug 14, 2018

BUY
$5.0 - $7.35 $270,185 - $397,171
54,037 New
54,037 $394,000

Others Institutions Holding ABUS

About Arbutus Biopharma Corp


  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $544M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.